anchor instance (Q86466)

From ScienceSource
Jump to: navigation, search
No description defined
edit
Language Label Description Also known as
English
anchor instance
No description defined

    Statements

    doses of pemafibrate (0.1, 0.2 or 0.4 mg) resulted in significantly greater reduction in TGs than
    0 references
    100 mg/day (by 45–52% versus 38%, p < 0.01), although the response was similar to fenofibrate 200 mg
    0 references
    326
    0 references
    99
    0 references
    27,175
    0 references
    16 April 2019
    0 references
    0 references
    Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia. (5628452)
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit